Corient Capital Partners’s Baker Hughes BKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$419K Buy
14,529
+234
+2% +$5.86K 0.03% 378
2022
Q2
$412K Buy
14,295
+1,369
+11% +$46.3K 0.03% 390
2022
Q1
$471K Buy
12,926
+2,037
+19% +$61.8K 0.03% 402
2021
Q4
$262K Buy
10,889
+637
+6% +$15.7K 0.02% 565
2021
Q3
$254K Buy
10,252
+528
+5% +$11.8K 0.02% 553
2021
Q2
$222K Buy
+9,724
New +$224K 0.02% 595
2020
Q2
Sell
-29,830
Closed -$314K 496
2020
Q1
$314K Buy
+29,830
New +$560K 0.05% 289

Other funds holding BKR

Corient Capital Partners's BKR Position: Q3 2022 in Review

Corient Capital Partners increased its Baker Hughes (BKR) stake by 1.6% in Q3 2022, buying an estimated $5.86K and bringing the position to 14,529 shares worth $419K. The position accounts for 0.03% of the portfolio, ranked #378.

Corient Capital Partners first reported a position in BKR in Q1 2020 and has held it in 7 quarters since. The position peaked at $471K in Q1 2022. 599 funds tracked by Wall St. Rank hold BKR as of Q3 2022.

  • Corient Capital Partners held 14,529 shares of Baker Hughes worth $419K as of Q3 2022.
  • Corient Capital Partners bought 234 Baker Hughes shares in Q3 2022, an estimated $5.86K.
  • Baker Hughes made up 0.03% of Corient Capital Partners's portfolio in Q3 2022, its #378 holding.
  • Corient Capital Partners first reported a position in Baker Hughes in Q1 2020 and has held it in 7 quarters since.
  • Corient Capital Partners's Baker Hughes position peaked at $471K in Q1 2022.
  • 599 funds tracked by Wall St. Rank held Baker Hughes as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.